These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8385308)

  • 21. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrolides in the management of streptococcal pharyngitis/tonsillitis.
    Tarlow MJ
    Pediatr Infect Dis J; 1997 Apr; 16(4):444-8. PubMed ID: 9109157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
    Zuckerman JM; Qamar F; Bono BR
    Infect Dis Clin North Am; 2009 Dec; 23(4):997-1026, ix-x. PubMed ID: 19909895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New therapeutic uses of the macrolides].
    Mihălţan F
    Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
    [No Abstract]   [Full Text] [Related]  

  • 26. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
    Zuckerman JM
    Infect Dis Clin North Am; 2004 Sep; 18(3):621-49, xi-. PubMed ID: 15308279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
    Suarez-Mier G; Giguère S; Lee EA
    J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New macrolide antibiotics: clarithromycin and azithromycin.
    Stott GA
    Am Fam Physician; 1992 Sep; 46(3):863-9. PubMed ID: 1325106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.
    Aoyama T; Sunakawa K; Iwata S; Takeuchi Y; Fujii R
    J Pediatr; 1996 Nov; 129(5):761-4. PubMed ID: 8917247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution and role of macrolides in infectious diseases.
    Blondeau JM
    Expert Opin Pharmacother; 2002 Aug; 3(8):1131-51. PubMed ID: 12150692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.
    Tiwari T; Murphy TV; Moran J;
    MMWR Recomm Rep; 2005 Dec; 54(RR-14):1-16. PubMed ID: 16340941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S
    Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
    Hatipoglu ON; Tasan Y
    Yonsei Med J; 2000 Jun; 41(3):340-4. PubMed ID: 10957888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics in treating oral-facial infections of odontogenic origin: an update.
    Wynn RL; Bergman SA; Meiller TF; Crossley HL
    Gen Dent; 2001; 49(3):238-40, 242, 244 passim. PubMed ID: 12004720
    [No Abstract]   [Full Text] [Related]  

  • 38. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
    Veber B; Pocidalo JJ
    Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrolides: clarithromycin and azithromycin.
    Wiedermann BL
    Pediatr Rev; 1998 Jul; 19(7):238-9. PubMed ID: 9654947
    [No Abstract]   [Full Text] [Related]  

  • 40. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.